- Initial training, continuing education
- 50-60 hours over 2 weeks (February-June each year)
Pharmacometrics is a rapidly evolving and growing field. There is an urgent need of trained experts capable of performing and evaluating population PKPD studies with various purposes, such as R&D of new pharmaceuticals, treatment optimization and individualization. This course will give you the theoretical and technical knowledge to accurately perform, interpret and evaluate complex PKPD models..
The objective of the course is for the attendees to master the concepts and the in silico tools for population models. The concepts include statistical inference, algorithms, components of population models, parametric vs non-parametric modeling, covariate modeling, complex pharmacokinetic, pharmacodynamic (efficacy, toxicity) and joint models, population model evaluation, optimal design, simulations. The attendees will practice on Monolix, NONMEM, Phoenix, R and matlab during hands-ons.
Organization of the training
The course will last over 2 weeks, either consecutive or separated by 1 or more weeks. The 50-60 hours of teaching will be divided in 50% theory and 50% hands-ons on usual mathematical and population modeling softwares. The last day will be devoted to an evaluation of the acquired skills.
The course is intended to post-graduate students or professionals having already attended the "Fundamentals for modeling and simulation in pharmacokinetics/pharmacodynamics " course. Validating both courses will lead to the delivery of the university diploma "Modeling and simation: population approaches in pharmacokinetics/pharmacodynamics", which will certify an advanced level in population modeling, which is sought for various positions in the pharmaceutical industry and in regulatory drugs or toxicology agencies.
Previous validation of the course "Fundamentals for modeling and simulation in pharmacokinetics/pharmacodynamics" is a pre-requisite.
The course will be animated by diverse recognized experts of each subject, professionals from the academia (French and international) and from the industry (Pharma companies, CROs).
The courses will be given in English.